-+ 0.00%
-+ 0.00%
-+ 0.00%

Resolet wins $305,000 NSF SBIR Phase I award for drug monitoring platform

PUBT·08/12/2026 19:36:58
Listen to the news
Resolet wins $305,000 NSF SBIR Phase I award for drug monitoring platform
  • Gener8tor named five startups for the Summer 2026 IU Health Incubator at IU LAB Pre-Accelerator cohort in Indianapolis.
  • Selected companies: Resolet, NeuroCoolX, Vicentrix, ResperCare, VitaWave.
  • Program runs seven weeks on a non-equity basis, positioning participants for customer traction, mentor access, investor connections.
  • Resolet cited a working benchtop prototype, backed by a $305,000 NSF SBIR Phase I award to advance its sensing platform.
  • Cohort pitches scheduled for Aug. 27 at a public showcase in Indianapolis.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gener8tor Management LLC published the original content used to generate this news brief on August 12, 2026, and is solely responsible for the information contained therein.